Company news
Xeris Biopharma Holdings, Inc. news in 2023
Xeris Biopharma Holdings, Inc.'s news releases, calls and decks from 2023, newest first.
Xeris Biopharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 26, 2023
Xeris Biopharma Reports Third Quarter 2023 Financial Results
November 8, 2023
Xeris Biopharma Raises Full-Year Financial Guidance and Reaffirms Cash Flow Breakeven in Q4 2023
October 15, 2023
Xeris Biopharma Announces Private Convertible Note Exchange Transactions
September 26, 2023
Xeris to Participate in the 2023 Cantor Global Healthcare Conference
September 13, 2023
Xeris to Participate at the H.C. Wainwright 25th Annual Global Investment Conference
August 27, 2023
Xeris Biopharma Reports Second Quarter 2023 Financial Results
August 7, 2023
Xeris Biopharma to Report Second Quarter 2023 Financial Results on August 8, 2023
July 31, 2023
Xeris Ships One Millionth Gvoke® Unit
July 30, 2023
Xeris Biopharma reaches Phase 2 milestone by dosing first participant in hypothyroidism study
June 21, 2023
Xeris Biopharma Announces First Participant Dosed in a Phase 2 Clinical Study of Its Investigational Subcutaneous (SC) Levothyroxine (XP-8121) in Patients With Hypothyroidism
June 20, 2023
Xeris Pharmaceuticals shares latest product and partnership updates
June 18, 2023
Xeris Biopharma to Participate at the Jefferies Healthcare Conference
May 31, 2023
Xeris Biopharma Reports First Quarter 2023 Financial Results
May 8, 2023
Xeris Biopharma to Report First Quarter 2023 Financial Results on May 9, 2023
May 1, 2023
Xeris Biopharma Announces Issuance of U.S. Patent Covering XeriSol™ Formulations
April 17, 2023
Xeris Biopharma enters research collaboration with Regeneron Pharmaceuticals to advance XeriJect
April 4, 2023
Xeris Biopharma Announces Research Evaluation Collaboration and Option Agreement With Regeneron for XeriJect™
March 29, 2023
Xeris Biopharma Appoints Ricki Fairley to Board of Directors
March 28, 2023
Xeris Biopharma Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides 2023 Financial Guidance
March 7, 2023
Xeris Biopharma to Report Fourth Quarter and Full-Year 2022 Financial Results on March 8, 2023
February 22, 2023
Xeris Biopharma to Participate in the SVB Securities Global Biopharma Conference 2023
February 1, 2023
Xeris Biopharma Announces FDA Grants Orphan-drug Exclusivity for Recorlev®
January 29, 2023
Xeris Biopharma Updates Its Outlook For 2022
January 4, 2023
Xeris Biopharma to Present at 41st Annual J.P. Morgan Healthcare Conference
January 4, 2023
Calls in 2023
- Xeris Biopharma Holdings (NASDAQ:XERS) Q3 2023 Earnings Call
Nov 9, 2023
Transcript - Xeris Biopharma Holdings (NASDAQ:XERS) Q2 2023 Earnings Call
Aug 8, 2023
Transcript - Xeris Biopharma Holdings (NASDAQ:XERS) Q1 2023 Earnings Call
May 9, 2023
Transcript - Xeris Biopharma Holdings (NASDAQ:XERS) Q4 2022 Earnings Call
Mar 8, 2023
Transcript